|
Duration of phase
|
|
< 4 h
|
50% (5676)
|
20% (2280)
|
30% (3419)
|
|
4–24 h
|
30% (3312)
|
45% (5067)
|
40% (4516)
|
|
> 24 h
|
14% (1622)
|
34% (3835)
|
27% (3006)
|
|
Not experiencing this phase
|
6% (656)
|
1% (84)
|
3% (325)
|
|
Proportion of individuals in each preventive treatment group reporting the duration of this migraine attack phase > 24 h:
|
|
- No failure to migraine preventive treatment
|
11% (250)
|
27% (599)
|
20% (436)
|
|
- 1 TF of migraine preventive treatment
|
11% (103)
|
29% (282)
|
23% (218)
|
|
- ≥2 TFs of migraine preventive treatment
|
17% (1114)
|
38% (2539)
|
31% (2048)
|
|
- P-value: ≥2 failures vs no failure of migraine preventative treatment
|
< 0.05
|
< 0.05
|
< 0.05
|
|
Feeling very to extremely limited during the phase
|
29% (3047)
|
71% (8023)
|
30% (3291)
|
